Economic evaluation of Neoral versus Sandimmune maintenance therapy for de novo liver transplant patients: results from an International Randomized Controlled Trial. Milton Study Group.
Peeters
P
P
Lewin Group, Paris, France.
Kazek
M
M
Abella
I
I
Noble
I
I
D000284:Administration, Oral; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D003365:Costs and Cost Analysis; D016572:Cyclosporine / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005060:Europe; D006801:Humans; D007165:Immunosuppression Therapy / Q000191:economics*; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D007391:International Cooperation; D007902:Length of Stay; D016031:Liver Transplantation / Q000191:economics* / Q000276:immunology*; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use; D016559:Tacrolimus / Q000627:therapeutic use; D014481:United States
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D016559:Tacrolimus; D008775:Methylprednisolone